Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,736 | 49,166 | 16,953 | 85,873 | 100,209 |
| Marketable Securities | 62,410 | 38,239 | 72,311 | 17,239 | 23,377 |
| Receivables | 1,347 | 530 | 1,248 | 568 | 770 |
| TOTAL | $133,710 | $95,952 | $94,215 | $109,167 | $131,425 |
| Non-Current Assets | |||||
| PPE Net | 60,090 | 61,526 | 63,027 | 65,087 | 66,444 |
| Investments And Advances | 0 | 56,409 | 56,203 | 55,686 | 53,678 |
| Intangibles | 25,798 | 25,798 | 25,798 | 25,798 | 25,798 |
| Other Non-Current Assets | 4,086 | 4,648 | 5,209 | 5,770 | 6,358 |
| TOTAL | $89,974 | $148,381 | $150,237 | $152,341 | $152,278 |
| Total Assets | $223,684 | $244,333 | $244,452 | $261,508 | $283,703 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 38,860 | 1,004 | 984 | 963 | 944 |
| Accounts payable and accrued liabilities | 3,413 | 3,210 | 3,083 | 7,926 | 8,055 |
| Accrued Expenses | 6,812 | 6,863 | 5,106 | 6,615 | 9,338 |
| TOTAL | $50,166 | $12,351 | $12,282 | $21,176 | $25,007 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,754 | 65,970 | 43,939 | 29,529 | 29,779 |
| Deferred Revenues | 1,081 | 1,274 | 3,109 | 5,672 | 6,670 |
| Other Non-Current Liabilities | 4,179 | 4,159 | 3,504 | 764 | 19,963 |
| TOTAL | $43,619 | $80,872 | $58,878 | $44,505 | $59,015 |
| Total Liabilities | $93,785 | $93,223 | $71,160 | $65,681 | $84,022 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,108 | 19,624 | 19,624 | 19,624 | 19,548 |
| Common Shares | 137 | 137 | 137 | 137 | 137 |
| Retained earnings | -548,170 | -529,028 | -508,955 | -487,395 | -471,978 |
| Other shareholders' equity | 386 | 4,000 | 7,465 | 10,247 | 38 |
| TOTAL | $129,899 | $151,110 | $173,292 | $195,827 | $199,681 |
| Total Liabilities And Equity | $223,684 | $244,333 | $244,452 | $261,508 | $283,703 |